Welcome to our dedicated page for Innovage Holding SEC filings (Ticker: INNV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
InnovAge Holding Corp. filings document the reporting framework for a Nasdaq-listed healthcare services company built around the Program of All-inclusive Care for the Elderly (PACE). Form 8-K reports furnish quarterly operating results, financial-condition updates, Regulation FD investor presentations, guidance-related materials, and governance events such as director appointments and executive transitions.
Proxy materials describe annual meeting matters, classified-board elections, committee governance, executive and director compensation, stockholder voting procedures, and auditor ratification. The filings also identify InnovAge common stock on the Nasdaq Global Select Market and include emerging-growth-company status, common-stock registration details, capital-structure information, and public-company reporting obligations tied to its PACE care model.
InnovAge Holding Corp. (INNV) announced a leadership change. On October 17, 2025, the Company and Michael Scarbrough agreed that he will leave his role as President and Chief Operating Officer, effective November 28, 2025. The Company and Mr. Scarbrough are working together to ensure a smooth transition, and a search has begun to fill the position.
InnovAge Holding Corp. (INNV) filing shows that Delk Meredith, listed as Chief Administrative Officer and director, submitted an initial Form 3 reporting no beneficial ownership of the issuer's securities. The report lists the triggering event date as 09/30/2025 and is signed by a power of attorney on 10/09/2025. The filing confirms the officer relationship and indicates no direct or indirect securities held at the time of the statement.
InnovAge Holding Corp. operates the largest PACE platform by participants, serving ~7,740 participants through 20 centers across six states and managing care under fully capitated contracts. The company receives virtually all revenue from PACE (99.8%), giving it recurring per-member payments and visibility into revenue; InnovAge estimates an average annual revenue opportunity of $115,000 per participant (or $9,600 PMPM) and reports an average Medicare RAF score of 2.42, reflecting a higher-acuity population. Clinical outcomes and operations highlights include approximately 93% of participants living safely at home and reported lower readmission rates versus comparable populations. Key financial and legal items disclosed include $60.0 million principal term loan, a $2.2 million convertible term loan classified as held for sale, and a securities class action settlement of $27.0 million with the company’s net share of $10.1 million. The filing emphasizes material regulatory, compliance and litigation risks, concentrated payor dependence on Medicare and Medicaid, cybersecurity and data privacy exposures, and ongoing investments and transformation initiatives that may affect future profitability.
InnovAge Holding Corp. filed a report describing that it released its financial results for the fiscal fourth quarter and full year ended June 30, 2025. The company issued a press release on September 9, 2025 covering these results and related matters, and attached this release as Exhibit 99.1. The disclosure is furnished rather than filed, which limits how it is treated under securities laws, and it is not automatically incorporated into other securities or exchange act filings unless specifically referenced.
Blair P. T. Blair, Chief Executive Officer and director of InnovAge Holding Corp. (INNV), reported a routine disposition of company stock tied to equity vesting. On 09/01/2025 the reporting person had 5,056 shares withheld at a price of $3.83 to satisfy tax obligations related to the vesting and settlement of restricted stock units. After the withholding, the reporting person beneficially owned 714,126 shares of common stock. The filing indicates this was a tax-withholding action rather than an open-market sale.
Nicole D'Amato, Chief Legal Officer of InnovAge Holding Corp. (INNV), reported a transaction dated 08/15/2025 on a Form 4. The filing discloses 14,303 shares of Common Stock were disposed of at $3.43 per share pursuant to tax withholding related to the vesting and settlement of restricted stock units. After the withholding disposition, the reporting person beneficially owned 319,807 shares. The Form 4 was signed on 08/18/2025. The filing explicitly states the shares were withheld to satisfy tax obligations and does not indicate an open-market sale or change in control.